ORCID iD: 0000-0003-2419-7816
http://orcid.org/0000-0003-2419-7816
link

ResearchGate
https://www.researchgate.net/profile/Martin_Braun13
link

Author or co-author of 16 publications in journals with IF; 342 citations according to WOS (without self-citations), H-index = 10 (as of 2020).

Selected publications (according to WOS citation):

1) Pavelka K, Forejtová Š, Olejárová M, Gatterová J, Šenolt L, Špaček P, Braun M, Hulejová H, Šťovíčková J, Pavelková A: Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis.
Osteoarthritis Cartilage 2004;12(4):277-83. IF = 3.572
2) Šenolt L, Braun M, Olejárová M, Forejtová Š, Gatterová J, Pavelka K: Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann. Rheum. Dis. 2005;64(6):886-90. IF = 6.956
3) Kalousová M, Sulková S, Fialová L, Soukupová J, Malbohan IM, Špaček P, Braun M, Mikulíková L, Fořtová M, Hořejší M, Tesař V, Zima T.: Glycoxidation and inflammation in chronic haemodialysis patients.
Nephrol Dial Transplant. 2003;18(12):2577-81. IF = 2.607
4) Kalousová M, Zima T, Popov P, Špaček P, Braun M, Soukupová J, Pelinková K, Kientsch-Engel R: Advanced glycation end-products in patients with chronic alcohol misuse.
Alcohol Alcohol. 2004;39(4):316-20. IF = 1.714
5) Kalousová M, Novotný L, Zima T, Braun M, Vítek L: Decreased levels of advanced glycation end-products in patients with Gilbert syndrome.
Cell. Mol. Biol. 2005;51(4):387-92. IF = 1.018
6) Filková M, Šenolt L, Braun M, Hulejová H, Pavelková A, Šléglová O, Kupka K, Gatterová J, Pavelka K.: Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis.
Osteoarthritis Cartilage 2009;17(12):1615-1619. IF = 3.888
7) Tomčík M, Arima K, Hulejová H, Kuklová M, Filková M, Braun M, Běláček J, Novák M, Bečvář R, Vencovský J, Haluzík M, Gay S, Müller-Ladner U, Distler O, Šenolt L.: Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis.
Cytokine. 2012;58(2):165-168. IF = 3.019
8) Vaculík J, Braun M, Dungl P, Pavelka K., Štěpán J. J.: Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis.
BMC Musculoskeletal Disorders (2016) 17:308. IF = 1.739
9) Suchý T, Šupová M, Klapková E, Horný L, Rýglová Š, Žaloudková M, Braun M, Sucharda Z, Ballay R, Veselý J, Chlup H, Denk F: The Sustainable Release of Vancomycin and Its Degradation Products From Nanostructured Collagen/Hydroxyapatite Composite Layers.
Journal of Pharmaceutical Sciences 105 (2016) 1288-1294. IF = 2.713
10) Rýglová Š, Braun M, Suchý T: Collagen and Its Modifications-Crucial Aspects with Concern to Its Processing and Analysis.
Macromolecular Materials and Engineering 2017, 302(6), 1-29. IF = 2.690
11) Bečvář R, Hulejová H, Braun M, Štork J: Collagen degradation products and proinflammatory cytokines in systemic and localized scleroderma.
Folia Biol.-Prague 2007;53(2):66-68. IF = 0.387
12) Šenolt L, Braun M, Vencovský J, Šedová L, Pavelka K: Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.
Physiol. Res. 2007;56(6):771-777. IF = 1.505
13) Celec P, Hodosy J, Jáni P, Janega P, Kúdela M, Kalousová M, Holzerová J, Parrák V, Halčák L, Zima T, Braun M, Pecháň I, Murín J, Šebeková K.: Advanced glycation end products in myocardial reperfusion injury.
Heart Vessels. 2012;27(2):208-215. IF = 2.047
14) Braun M, Hulejová H, Gatterová J, Filková M, Pavelková A, Šléglová O, Kaspříková N, Vencovský J, Pavelka K, Šenolt L. Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritis.
Open Rheumatol J. 2012;6:64-69.
15) Kalousová M, Havrdová E, Mrázová K, Špaček P, Braun M, Uhrová J, Germanová A, Zima T: Advanced glycoxidation end products in patients with multiple sclerosis.
Prague Med. Rep. 2005;106(2):167-74.
16) Braun M.: Modern analytical approaches to determination of connective tissue degradation biomarkers.
Locomotor System – Advances in Research, Diagnostics and Therapy. 2010;17(3-4):282-293
17) Braun M, Rýglová Š, Suchý T. Determination of glycosaminoglycans in biological matrices using a simple and sensitive reversed-phase HPLC method with fluorescent detection.
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Mar 6;1173:122626. doi: 10.1016/j.jchromb.2021.122626. IF = 3.205
18) Rýglová Š, Braun M, Hříbal M, Suchý T, Vöröš D. The proportion of the key components analysed in collagen-based isolates from fish and mammalian tissues processed by different protocols.
Journal of Food Composition and Analysis (June 2021), doi: 10.1016/j.jfca.2021.104059. IF = 4.556
19) Šupová M, Suchý T, Chlup H, Štípek J, Žitný R, Landfeld A, Skočilas J, Žaloudková M, Rýglová Š, Braun M, Štancl J, Houška M.
The comprehensive evaluation of two collagen gels used for sausage casing extrusion purposes: The role of the structural and mechanical properties. Journal of Food Engineering 343 (2023) 11138, https://doi.org/10.1016/j.jfoodeng.2022.111387 , IF = 6.203